Root Financial Partners LLC Acquires 122 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Root Financial Partners LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 8.0% during the 4th quarter, HoldingsChannel.com reports. The fund owned 1,640 shares of the healthcare conglomerate’s stock after purchasing an additional 122 shares during the period. Root Financial Partners LLC’s holdings in UnitedHealth Group were worth $829,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of the company. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group during the 3rd quarter valued at $37,000. Friedenthal Financial bought a new position in shares of UnitedHealth Group in the third quarter worth $51,000. DecisionPoint Financial LLC raised its stake in shares of UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after purchasing an additional 62 shares during the period. Finally, Highline Wealth Partners LLC bought a new position in UnitedHealth Group in the 3rd quarter worth about $55,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.7 %

Shares of UnitedHealth Group stock opened at $531.31 on Friday. The company’s 50 day moving average price is $524.58 and its 200-day moving average price is $563.71. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market capitalization of $488.96 billion, a price-to-earnings ratio of 34.28, a P/E/G ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the business posted $5.83 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have recently issued reports on UNH. Piper Sandler lowered their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. KeyCorp restated an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Stephens increased their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Finally, HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research report on Friday, January 10th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $629.32.

Get Our Latest Report on UNH

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.